合成,表征和毒性评价的-酸电荷转移复合物:抗癌应用的潜力
Mahmoud M Ali1, Muhammad Alaa Eldeen2, Mohamed E El Awady3
1Chemistry Department, Faculty of Science, Zagazig University P.O. Box 44519 Zagazig Egypt.
RSC medicinal chemistry
|May 8, 2025
概括
这项研究合成了新型的电荷转移复合物 (CTC) 来自西普洛素 (CIP) 和氨酸. 该CTC显示出潜在的抗癌活性,并在细胞系和动物模型中评估了毒性.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 普洛素 (CIP) 是FDA批准的抗微生物药物,具有新兴的抗癌特性.
- 调查CIP更广泛的药理学影响是有必要的.
- 这项研究重点关注来自CIP的新型收费转移复合体 (CTC).
研究的目的:
- 合成新的电荷转移复合物 (CTC) 从西普洛素 (CIP) 和酸 (H2CA).
- 使用光谱学方法来表征合成的CTC.
- 评估新型CTCs的体外抗癌活性和体内毒性.
主要方法:
- 用于CTC特征的光谱技术 (UV可见,FT-IR,1H NMR) 进行.
- 用于在人体癌细胞上进行体外抗癌查的MTT测定.
- 在老鼠体内毒性评估,包括血液学,生化学和组织学分析.
主要成果:
- 一个明显的颜色变化证实了CIP和H2CA之间的CTC形成,其摩尔比例为1:1.
- 光谱数据阐明了固态CTCs的结构.
- 获得了合成复合物的初步毒性和抗癌活性数据.
结论:
- 一种新型的电荷转移复合物,由西普罗夫洛克萨和氨酸组成,已成功合成和特征化.
- 合成的CTC显示出潜在的抗癌活性.
- 该综合体的毒性概况在体外和体内都得到了评估,为进一步研究提供了基础.
相关概念视频
01:25Mutagenicity and Carcinogenicity
1.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.1K
01:46Electron Transport Chain: Complex I and II
9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.6K